244 related articles for article (PubMed ID: 7635557)
1. New skeletal muscle relaxants.
Caldwell JE
Int Anesthesiol Clin; 1995; 33(1):39-60. PubMed ID: 7635557
[TBL] [Abstract][Full Text] [Related]
2. Update on newer neuromuscular blocking drugs.
Holm H; Ostergaard D
Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):108-13. PubMed ID: 7710219
[TBL] [Abstract][Full Text] [Related]
3. Newer neuromuscular blocking agents.
Bevan DR
Pharmacol Toxicol; 1994 Jan; 74(1):3-9. PubMed ID: 8159634
[TBL] [Abstract][Full Text] [Related]
4. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
Mirakhur RK
Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013
[TBL] [Abstract][Full Text] [Related]
5. Mivacurium chloride--a comparative profile.
Diffenbach C; Buzello W; Mellinghoff H
Acta Anaesthesiol Scand Suppl; 1995; 106():23-5. PubMed ID: 8533540
[TBL] [Abstract][Full Text] [Related]
6. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
Kim KS; Chun YS; Chon SU; Suh JK
Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
[TBL] [Abstract][Full Text] [Related]
7. New developments in nondepolarizing muscle relaxants.
Mirakhur RK
Yale J Biol Med; 1993; 66(5):463-71. PubMed ID: 7825348
[TBL] [Abstract][Full Text] [Related]
8. Use of intermediate acting muscle relaxants by infusion: the future.
Mirakhur RK; McCourt KC; Kumar N
Acta Anaesthesiol Belg; 1997; 48(1):29-34. PubMed ID: 9099306
[TBL] [Abstract][Full Text] [Related]
9. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
Atherton DP; Hunter JM
Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167
[TBL] [Abstract][Full Text] [Related]
11. Muscle relaxants: a clinical update.
Buzello W; Diefenbach C; Nigrovic V
Acta Anaesthesiol Scand Suppl; 1996; 109():165-7. PubMed ID: 8901994
[TBL] [Abstract][Full Text] [Related]
12. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
[TBL] [Abstract][Full Text] [Related]
13. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
Ma H; Zhuang X
Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
[TBL] [Abstract][Full Text] [Related]
14. [New muscle relaxants].
Watanabe K
Masui; 2001 Dec; 50 Suppl():S144-50. PubMed ID: 11871089
[No Abstract] [Full Text] [Related]
15. Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration.
Kopman AF; Klewicka MM; Kopman DJ; Neuman GG
Anesthesiology; 1999 Feb; 90(2):425-31. PubMed ID: 9952148
[TBL] [Abstract][Full Text] [Related]
16. Rocuronium is the best non-depolarizing relaxant to prevent succinylcholine fasciculations and myalgia.
Martin R; Carrier J; Pirlet M; Claprood Y; Tétrault JP
Can J Anaesth; 1998 Jun; 45(6):521-5. PubMed ID: 9669004
[TBL] [Abstract][Full Text] [Related]
17. Choice of the muscle relaxant for rapid-sequence induction.
Sparr HJ
Eur J Anaesthesiol Suppl; 2001; 23():71-6. PubMed ID: 11766251
[TBL] [Abstract][Full Text] [Related]
18. Rocuronium onset of action: a comparison with atracurium and vecuronium.
Bartkowski RR; Witkowski TA; Azad S; Lessin J; Marr A
Anesth Analg; 1993 Sep; 77(3):574-8. PubMed ID: 8103649
[TBL] [Abstract][Full Text] [Related]
19. The potency of mixtures of mivacurium and atracurium or vecuronium.
Kopman AF
Anesth Analg; 1995 Jul; 81(1):207-8. PubMed ID: 7598267
[No Abstract] [Full Text] [Related]
20. [Modern muscle relaxants and their clinical application].
Mellinghoff H
Anaesthesist; 1994 Apr; 43(4):270-82. PubMed ID: 8179178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
